Bio-Process Systems Alliance Announces 2026 – 2027 Board Election Results

December 11, 2025, 2025 (ARLINGTON, VA) – The Bio-Process Systems Alliance (BPSA), the international association for the single-use bioprocessing industry, has announced its newly elected Board members for the 2026–2027 term.

Todd Andrews, Global Director of Application and Business Development, Biopharma at CPC, was re-elected as Secretary for a second two-year term. Ravi Narayanan, Commercial Vice President, Fluid Management & Flexibles at DuPont Healthcare Solutions, was re-elected as Treasurer for a second two-year term. Andrews has more than 20 years of experience in the single-use biopharma industry, focusing on connection technology, and has been an active BPSA member for over 15 years. Narayanan brings over 20 years of experience serving the biopharma and medical device industries and has previously led global product management for biopharma single-use components at Nordson Medical.

Two new Directors-at-Large were elected for two-year terms: Sade Mokuolu, PhD, Regional Business Development and Marketing Manager at Watson-Marlow Fluid Technology Solutions (WMFTS), and Brian Horowski, Director, Process Technologist at IPS. Mokuolu has held a range of senior business and technical positions, including strategy implementation lead, global regulatory and validation services manager, and actively contributes to multiple industry workstreams. Horowski has more than 20 years of experience in facility design for bulk drug substance manufacturing, including monoclonal antibodies, recombinant proteins, gene therapies, and vaccines.

Additionally, Monica Cardona (MilliporeSigma), Brian Chung (Syensqo), Dianne Heiler (Repligen Corporation), John Puglia, PhD (Thermo Fisher Scientific), and Thomas Vandromme (Meissner) were re-elected as Directors-at-Large for two-year terms (2026–2027).

“Congratulations to Todd and Ravi on their re-election as Secretary and Treasurer. I appreciate that they have volunteered to continue managing significant roles in our organization,” said BPSA Chair Mark Petrich of Krystal Biotech, Inc. “I also congratulate all our new and returning Board members. Their extensive experience and leadership will be essential in guiding the Alliance forward. On behalf of the BPSA, I offer a special thanks to Jayanthi Grebin of JLG Life Science LLC and Chris Wilkins, PhD, of Filtration Group for their invaluable contributions as Directors-at-Large as their terms conclude this year.” Petrich continued, “For more than 20 years, BPSA has facilitated the growth of single-use technologies and contributed to their implementation in critical biopharmaceutical manufacturing operations. Single-use technologies are important tools in the quest to improve the health of patients and consumers. I look forward to working with this talented board of directors to address opportunities and needs in our industry.”

BPSA Executive Board Officers:
Chair: Mark Petrich, PhD, Krystal Biotech
1st Vice Chair: Todd Kapp, Kivi Bio, LLC
2nd Vice Chair: Kirsten Strahlendorf, Sanofi
Secretary: Todd Andrews, CPC
Treasurer: Ravi Narayanan, DuPont

At-Large Directors (newly elected through 2027):
Brian Horowski, IPS
Sade Mokuolu, PhD, Watson-Marlow

At-Large Directors (continuing through 2026/2027):
Monica Cardona, MilliporeSigma
Brian Chung, Syensqo
Ralph Daumke, PendoTECH
Patrick Evrard, Cytiva
Dianne Heiler, Repligen Corporation
Charlotte Masy, PhD, GSK
Hernán Parma, RENOLIT Healthcare
John Puglia, PhD, Thermo Fisher Scientific
Stuart Tindal, EngD, PhD, Sartorius
Thomas Vandromme, Meissner
Ping Wang, PharmD, Johnson & Johnson

Board members are elected by BPSA’s general membership to serve staggered two-year terms. They establish governing policies, determine budget priorities, and set strategic goals to advance the Alliance and its mission of supporting the single-use bioprocessing industry globally. Click here for a complete list of BPSA Board of Directors.

About BPSA:  An affiliate of SOCMA, The Bio-Process Systems Alliance (BPSA), is an industry-led association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. BPSA facilitates education, best practice sharing, and networking opportunities among its member companies. For more information, visit www.bpsalliance.org.